D-0927-2018 Class II Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-0927-2018 was initiated by LUPIN SOMERSET on Jun 28, 2018 and is designated Class II. Reason for recall: Subpotent Drug and Failed Content Uniformity. The recall status is terminated (terminated Mar 6, 2023). Affected quantity: 3456 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 18, 2018
Initiation Date
Jun 28, 2018
Termination Date
Mar 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3456 cartons

Product description

Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11

Reason for recall

Subpotent Drug and Failed Content Uniformity.

Distribution pattern

Nationwide within the US

Code information

Lot#: S700065, Exp. 02/2019; 700619, Exp. 08/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0927-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0927-2018. Report a data issue: hello@regdatalab.com.